Article
Investigational RNA Interference Agents for Hepatitis B
7 Dec 2024
Abstract excerpt
Functional cure of chronic hepatitis B (CHB)-defined as sustained seroclearance of hepatitis B surface antigen (HBsAg) with unquantifiable hepatitis B virus (HBV) DNA at 24 weeks off treatment, is an optimal treatment endpoint. Nonetheless, it cannot be consistently attained by current treatment modalities. RNA interference (RNAi) is a novel treatment strategy using small-interfering RNA (siRNA) or antisense...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
